[go: up one dir, main page]

FR2952826B1 - USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS - Google Patents

USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS

Info

Publication number
FR2952826B1
FR2952826B1 FR0958214A FR0958214A FR2952826B1 FR 2952826 B1 FR2952826 B1 FR 2952826B1 FR 0958214 A FR0958214 A FR 0958214A FR 0958214 A FR0958214 A FR 0958214A FR 2952826 B1 FR2952826 B1 FR 2952826B1
Authority
FR
France
Prior art keywords
multipurpose
immunoglobulins
hepatic cirrhosis
treating alcoholic
metabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0958214A
Other languages
French (fr)
Other versions
FR2952826A1 (en
Inventor
Zera Tellier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LFB SA filed Critical LFB SA
Priority to FR0958214A priority Critical patent/FR2952826B1/en
Priority to ARP100104283A priority patent/AR079080A1/en
Priority to PCT/FR2010/052460 priority patent/WO2011061454A1/en
Publication of FR2952826A1 publication Critical patent/FR2952826A1/en
Application granted granted Critical
Publication of FR2952826B1 publication Critical patent/FR2952826B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR0958214A 2009-11-20 2009-11-20 USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS Expired - Fee Related FR2952826B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0958214A FR2952826B1 (en) 2009-11-20 2009-11-20 USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS
ARP100104283A AR079080A1 (en) 2009-11-20 2010-11-19 COMPOSITION OF POLIVALENT IMMUNOGLOBULINS TO TREAT AN ALCOHOLIC OR METABOLIC HEPATIC CIRROSIS
PCT/FR2010/052460 WO2011061454A1 (en) 2009-11-20 2010-11-19 Use of polyvalent immunoglobulins for treating alcoholic or metabolic liver cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0958214A FR2952826B1 (en) 2009-11-20 2009-11-20 USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS

Publications (2)

Publication Number Publication Date
FR2952826A1 FR2952826A1 (en) 2011-05-27
FR2952826B1 true FR2952826B1 (en) 2012-04-06

Family

ID=42122872

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0958214A Expired - Fee Related FR2952826B1 (en) 2009-11-20 2009-11-20 USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS

Country Status (3)

Country Link
AR (1) AR079080A1 (en)
FR (1) FR2952826B1 (en)
WO (1) WO2011061454A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4458C1 (en) * 2014-06-19 2017-08-31 Мария ДАНУ Use of Polybiolin drug in patients with liver cirrhosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE501476C2 (en) 1992-10-21 1995-02-27 Nilsson Carl O Lennart Cylinder bolt mechanism at repeater rifle
IL135993A0 (en) * 2000-05-05 2001-05-20 Omrix Biopharmaceuticals Pharmaceutical composition for the treatment of fibrosis
FR2824568B1 (en) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement PROCESS FOR THE PREPARATION OF HUMAN IMMUNOGLOBULIN CONCENTRATES FOR THERAPEUTIC USE
FR2853551B1 (en) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM
FR2895263B1 (en) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement CONCENTRATE OF IMMUNOGLOBIN G (LG) DEPLETED ANTI-A AND ANTI-B ANTIBODIES, AND POLYREACTIVE IGG

Also Published As

Publication number Publication date
AR079080A1 (en) 2011-12-21
WO2011061454A1 (en) 2011-05-26
FR2952826A1 (en) 2011-05-27

Similar Documents

Publication Publication Date Title
EP2627334A4 (en) METHODS AND COMPOSITIONS FOR POLYMERASE INHIBITION
EP2668206A4 (en) GENETIC MODIFICATION OF DOMAINS OF IMMUNOGLOBULINS
EP2764006A4 (en) MODIFIED SOPHOROLIPIDES FOR THE INHIBITION OF PHYTOPATHOGENS
EP2734839A4 (en) COMPENSATED PATCH-CLAMP AMPLIFIER FOR THE SEQUENCING OF NANOPORE POLYNUCLEOTIDES AND OTHER APPLICATIONS
EP2554175A4 (en) COMPOSITION FOR THE TREATMENT OF A DESIRED PART
EP2704743A4 (en) COMPOSITIONS FOR INHIBITING MASP-2 DEPENDENT SUPPLEMENT ACTIVATION
EP2825694A4 (en) AFFINITY REAGENTS FOR THE PURIFICATION OF PROTEINS
EP2732037A4 (en) GENES AND PROTEINS FOR THE SYNTHESIS OF ALKANOYL-COA
EP2229132A4 (en) COSMETIC COMPOSITIONS FOR CONFERRING SUPERHYDROPHOBIC FILMS
EP2459208A4 (en) THERAPEUTIC AGENTS FOR REDUCING PARATHYROIDAL HORMONE LEVELS
EP2531915A4 (en) DECLARATIVE EXTENSION POINT REGISTRATION FOR VIRTUALIZATION
EP2670435A4 (en) USE OF ANTI-DKK1 MONOCLONAL ANTIBODY FOR THE TREATMENT OF LIVER CANCER
EP2402431A4 (en) AGENT FOR THE PREVENTION OR IMPROVEMENT OF OBESITY
FR2962650B1 (en) COMPOSITION OF HUMAN CONCENTRATED IMMUNOGLOBULINS
EP2639279A4 (en) COMPOSITION FOR VULCANIZING ADHESION
EP2621872A4 (en) MILLING ADDITIVE COMPOSITION FOR CEMENT STABLE AT DILUTION
EP2934432A4 (en) COMPOSITION FOR ORAL HYGIENE
EP2543660A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY
EP2151919A4 (en) MIXER OF HARMONIC PAIRS
EP2931280A4 (en) METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1
EP2368559A4 (en) COMPOSITION FOR PREVENTING OR TREATING ATHEROSCLEROSIS
EP2818163C0 (en) Composition for nasal application having improved stability
EP2245931A4 (en) EMULSION COMPOSITION
FR2961107B1 (en) HUMAN IMMUNOGLOBULIN COMPOSITION STABILIZED
EP2245930A4 (en) EMULSION COMPOSITION

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140731